QL-535

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameQL-535
Drug Alias NameQL-535QL535
ClassificationBiologics > T cell engagers
Mechanisms of ActionCD3 T-cell engagers
TargetsT cell surface glycoprotein CD3
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQlsf Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesQlsf Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A